ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 129 for:    Recruiting, Not yet recruiting, Available Studies | "Osteosarcoma"

Biology of Osteosarcoma (BOOST) Registry and Biobank (BOOST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03225872
Recruitment Status : Recruiting
First Posted : July 21, 2017
Last Update Posted : July 25, 2017
Sponsor:
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute

Brief Summary:
Osteosarcoma is very rare cancer of the bone. The investigator started the BOOST registry and biobank to make sure every patient has the opportunity to participate in research.

Condition or disease
Osteosarcoma

Detailed Description:

Summary to include:

  1. Samples of saliva, blood and/or other stored material such as slides or leftover diagnostic material. If available the investigator may ask you for deciduous (baby) teeth.
  2. Questionnaire information, including health history, growth and development, physical activity and family medical history information.
  3. If you have been diagnosed with a osteosarcoma or another condition the investigator is interested inthe investigator will ask you release medical record information relating to diagnosis and treatment of osteosarcoma, other cancers, blood disorders, and similar conditions. If this step applies to you then you will be asked to sign a separate form.
  4. You may be asked to contact your biological parents and full biological siblings to ask them about participating in the study.
  5. If you agree you may be contacted in the future. You will be able to decline any future information or studies at any point.

Study Type : Observational
Estimated Enrollment : 5000 participants
Observational Model: Family-Based
Time Perspective: Retrospective
Official Title: Biology of Osteosarcoma (BOOST) Registry and Biobank
Actual Study Start Date : January 3, 2017
Estimated Primary Completion Date : December 2050
Estimated Study Completion Date : December 2050

Resource links provided by the National Library of Medicine


Group/Cohort
Osteosarcoma patients and family members
Osteosarcoma patients and family members



Primary Outcome Measures :
  1. Determine if genes can determine osteosarcoma [ Time Frame: Baseline ]
    To do this the investigator will compare the genes of people with osteosarcoma to the genes of people who do not have these conditions.


Biospecimen Retention:   Samples With DNA
The investigator will collect saliva and if available baby teeth. There will be no cost to you. If the investigator finds out that your sample doesn't have enough cells to be useful, the investigator may call you for an additional sample.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Worldwide
Criteria

Inclusion Criteria:

  • Proband Inclusion criteria: A diagnosis or suspected diagnosis of osteosarcoma (ICCC 9180-9200)

Family member inclusion criteria: Biological parents and full biological siblings of a case diagnosed with osteosarcoma (ICCC 9180-9200)

Exclusion Criteria:

  • Does not understand English.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03225872


Contacts
Contact: Michelle A Roesler, BS 1-866-434-9879 roesl003@umn.edu
Contact: Colleen Geary Carter, MS 1-866-434-9879 osteo@umn.edu

Locations
United States, Minnesota
Masonic Cancer Center Recruiting
Minneapolis, Minnesota, United States, 55455
Contact: Michelle A Roesler, BS    612-624-8933      
Principal Investigator: Logan G Spector, PhD         
Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
Investigators
Principal Investigator: Logan G. Spector, PhD University of Minnesota - Clinical and Translational Science Institute

Responsible Party: University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier: NCT03225872     History of Changes
Other Study ID Numbers: 1604M86750
First Posted: July 21, 2017    Key Record Dates
Last Update Posted: July 25, 2017
Last Verified: July 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:
Osteosarcoma
Bone cancer
Family-based study

Additional relevant MeSH terms:
Osteosarcoma
Neoplasms, Bone Tissue
Neoplasms, Connective Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms
Sarcoma